Coldstream Capital Management Inc Ultragenyx Pharmaceutical Inc. Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RARE
# of Institutions
333Shares Held
89MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$389 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$218 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$162 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$125 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$102 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.72B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...